Headlines
-
Virtual pharmacy school
Wednesday | Dec 6 2017THE School of Pharmacy at Griffith University has announced the adoption of "dramatic new virtual reality and augmented reality technology" to provide a new immersive learning environment for students.
-
ACCC targets GSK, Novartis
Wednesday | Dec 6 2017THE Australian Competition and Consumer Commission (ACCC) has launched Federal Court proceedings against GSK Australia and Novartis Consumer Health Australasia, alleging they made "false or misleading representations in the marketing of Voltaren Osteo Gel and Voltaren Emulget pain relief products".
-
MHRA targets online diet pills
Tuesday | Dec 5 2017BRITAIN'S Medicines and Healthcare products Regulatory Agency (MHRA) is urging people wanting to lose weight to turn to "safe, legitimate and appropriate routes," as part of a campaign against illicit diet tablets.
-
NSW discharge summaries in MHR
Tuesday | Dec 5 2017NSW Health has integrated its HealtheNet Clinical Portal with the Federal Government's My Health Record (MHR) system, meaning clinicians are able to view MHR data via the in-house portal.
-
Statins still most prescribed
Tuesday | Dec 5 2017THE top 10 drugs dispensed in Australia during the year Jul 2016 to Jun 2017 were dominated by blood pressure and cholesterol lowering drugs, with atorvastatin and rosuvastatin in positions one and two respectively for both pills popped per-day and prescription numbers dispensed.
-
Amazon for generic entry?
Monday | Dec 4 2017MEGAGIANT online retailer Amazon is said to be in discussions with generic pharmaceutical manufacturing companies around its potential entry into the pharmacy sector, according to a report from CNBC.
-
One PBS addition for Dec
Monday | Dec 4 2017JUST one medicine has been added to the Pharmaceutical Benefits Scheme this month, with funding approved for eribulin (Halaven) for the treatment of soft tissue sarcoma.
-
Pharmacy of the future
Monday | Dec 4 2017THE Pharmacy Guild of Australia has revealed further details of its "Community Pharmacy in 2025" research project (PD 14 Sep), with the appointment of consultant group Pottinger as strategic adviser.
-
Don’t sneeze at OTC relief
Friday | Dec 1 2017FOLLOWING mainstream media reports suggesting there is no role for oral antihistamines in the management of seasonal hayfever, the Australian Self Medication Industry (ASMI) has urged consumers who suffer from hayfever to discuss their symptoms with their doctor or pharmacist to ensure they receive the most appropriate treatment.
-
Symbion cuts trading terms
Friday | Dec 1 2017EBOS offshoot Symbion Health has reacted swiftly to the impact of AstraZeneca's decision to commence direct distribution, advising pharmacists of a reduction in trading terms effective today.